Clarus Wealth Advisors lessened its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 5.4% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,805 shares of the business services provider’s stock after selling 217 shares during the period. Clarus Wealth Advisors’ holdings in Exponent were worth $266,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Tower Research Capital LLC TRC lifted its position in shares of Exponent by 787.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 612 shares of the business services provider’s stock worth $36,000 after buying an additional 543 shares during the last quarter. NN Investment Partners Holdings N.V. purchased a new stake in shares of Exponent during the 2nd quarter worth approximately $91,000. Atria Investments LLC purchased a new stake in shares of Exponent during the 2nd quarter worth approximately $115,000. Cim LLC purchased a new stake in shares of Exponent during the 2nd quarter worth approximately $200,000. Finally, HighTower Advisors LLC purchased a new stake in shares of Exponent during the 2nd quarter worth approximately $240,000. Institutional investors own 88.08% of the company’s stock.
EXPO stock opened at $70.42 on Friday. The company has a fifty day moving average price of $70.12 and a 200 day moving average price of $62.50. Exponent, Inc. has a 12 month low of $44.44 and a 12 month high of $72.70. The company has a market cap of $3.62 billion, a price-to-earnings ratio of 48.76 and a beta of 0.41. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.60 and a quick ratio of 3.60.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were paid a $0.16 dividend. The ex-dividend date of this dividend was Thursday, September 5th. This represents a $0.64 annualized dividend and a yield of 0.91%. Exponent’s dividend payout ratio is currently 51.20%.
EXPO has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $81.00 price objective for the company in a research report on Monday, September 23rd. SunTrust Banks upped their price target on shares of Exponent from $70.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, September 20th. BidaskClub downgraded shares of Exponent from a “buy” rating to a “hold” rating in a research report on Thursday, September 26th. Cantor Fitzgerald upped their price target on shares of Exponent from $64.00 to $73.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Finally, DA Davidson began coverage on shares of Exponent in a research report on Wednesday, August 28th. They issued a “neutral” rating for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company’s stock. Exponent presently has an average rating of “Hold” and an average target price of $76.75.
In other Exponent news, insider John Pye sold 3,000 shares of the business’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $70.31, for a total value of $210,930.00. Following the transaction, the insider now directly owns 25,747 shares of the company’s stock, valued at approximately $1,810,271.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Richard L. Schlenker, Jr. sold 22,243 shares of the business’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $70.57, for a total transaction of $1,569,688.51. Following the completion of the transaction, the chief financial officer now directly owns 247,118 shares in the company, valued at $17,439,117.26. The disclosure for this sale can be found here. Insiders sold a total of 102,773 shares of company stock worth $7,227,536 over the last three months. 2.30% of the stock is currently owned by corporate insiders.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Read More: What is the return on assets (ROA) ratio?
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.